A trio of takeovers by Goldman, Morgan Stanley, and Schwab unlocks new opportunities – and potential risks – for retail investors.
All figures in Canadian dollars unless otherwise noted Highlights: Net assets increase by $45.8 billion 10-year net return of ...
Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that it has entered into a definitive arrangement agreement (the ...
GlobalData on MSN
Raising the bar: can higher drug spending in the UK deliver for pharma and patients?
The UK considers raising NICE’s cost-effectiveness threshold, testing the balance between funding innovation and conserving ...
On Monday 10 November, techUK President Sheila Flavell CBE and the Invest in Women Taskforce's Head of Strategic Engagement Juliet Gouldman convened leading voices from across the tech ecosystem to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback